leisure time -WSS

leisure time

author：explore 2025-09-30 00:08:53 - browse：761

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits.

The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health. Novo is testing Wegovy, a weekly injection also sold under the brand name Ozempic for type 2 diabetes, against placebo in the five-year study.

The implications are massive, and not just for Novo. Wegovy is part of a class of medicines that target a hormone called GLP-1, which curbs patients’ appetites. Those drugs have demonstrated an ability to help people lose dramatic amounts of weight in clinical trials, but payers, including Medicare, have been slow to reimburse for them without definitive data on their long-term health benefits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： A Greenpeace activist is fined for crash

WSS

Blinken talks high

Inflation cooled significantly in June, bringing price hikes close to normal levels

Companies helping big Covid

Antibody drugs appear effective. Now can we make enough of them?

U.S. death rates show how politics are affecting public health

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

knowledge

leisure time

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Decentralized clinical trials need collaboration to achieve wider use

Affirmative action in medical school literally saved lives

Blinken talks high

What does generative AI mean for health care? We asked experts

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Sports medicine is finally prioritizing gender equality

Decentralized clinical trials need collaboration to achieve wider use

Duchenne breakthrough therapy leaves behind pioneering families

Medical students need to learn the potent medicine of empathy

explore

Britney Spears to release memoir, 'The Woman In Me,' later this year

How are insurers handling Leqembi and related scans?

The world needs the new pandemic treaty

Medical students need to learn the potent medicine of empathy

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Superbugs, antibiotic resistance get scrutiny in congress

leisure time

hotspot

hotspot

focus